首页> 外文期刊>Psychopharmacology >Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats.
【24h】

Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats.

机译:自发性高血压大鼠的哌醋甲酯治疗:与Wistar大鼠相比,对哌醋甲酯自我给药和恢复的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Methylphenidate is a psychostimulant given for extended periods of time as a treatment of attention-deficit/hyperactivity disorder (ADHD). The long-term effects of the drug are not yet known, and it is speculated that repeated exposure may produce drug dependence.To investigate the effects of repeated methylphenidate treatment on methylphenidate self-administration and reinstatement in the most validated animal model of ADHD, the spontaneously hypertensive rat (SHR), and Wistar rat, strain representing the "normal" heterogeneous population.Rats were administered intraperitoneally with saline or methylphenidate (2?mg/kg) for 14?days, prior to experiments. Thereafter, responses for intravenous methylphenidate under the fixed ratio (FR1 and FR3) and progressive ratio (PR) schedules were assessed. Extinction experiments followed, as well as tests to determine the ability of intraperitoneal administration of methylphenidate (2 and 5?mg/kg) to reinstate extinguished drug-seeking behaviors in rats.Previous exposure to methylphenidate enhanced methylphenidate self-administration in Wistar rats but not in SHR (FR3). Methylphenidate pretreatment reduced responding for methylphenidate in SHR but did not affect self-administration behaviors of Wistar rats (PR). Methylphenidate pre-exposure robustly reinstated drug-seeking behaviors in Wistar rats, but not in SHR.The contrasting effects of repeated methylphenidate treatment in methylphenidate self-administration and reinstatement in Wistar and SHR, and the increased susceptibility of the Wistar rat strain to the reinforcing effects of methylphenidate indicate that "normal" individuals are more likely to develop psychological dependence to the drug and experience relapse. Meanwhile, the clinical use of methylphenidate may not produce drug dependence or relapse in ADHD patients.
机译:哌醋甲酯是长期服用的一种精神兴奋剂,可用于治疗注意力缺陷/多动症(ADHD)。该药物的长期作用尚不清楚,推测重复接触可能会产生药物依赖性。在最有效的ADHD动物模型中,要研究重复哌醋甲酯治疗对哌醋甲酯自我给药和恢复的影响,自发性高血压大鼠(SHR)和Wistar大鼠,代表“正常”异质群体。在实验前,给大鼠皮下腹腔注射生理盐水或哌醋甲酯(2?mg / kg)14?天。此后,评估固定比率(FR1和FR3)和渐进比率(PR)方案下静脉注射哌醋甲酯的反应。随后进行了灭绝实验以及确定腹膜内施用哌醋甲酯(2和5?mg / kg)恢复大鼠灭绝药物行为的能力的试验。在SHR(FR3)中。哌醋甲酯预处理可减少SHR对哌醋甲酯的反应,但不影响Wistar大鼠(PR)的自我给药行为。哌醋甲酯预暴露可在Wistar大鼠中强烈恢复药物寻求行为,但在SHR中则不然。重复哌醋甲酯治疗在Wistar和SHR中哌醋甲酯自我给药和恢复的对比作用,以及Wistar大鼠品系对增强药物的敏感性增加哌醋甲酯的作用表明“正常”个体更可能对药物产生心理依赖性并经历复发。同时,哌醋甲酯的临床使用可能不会在ADHD患者中产生药物依赖性或复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号